TY - JOUR T1 - Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e18 LP - e18 DO - 10.1136/annrheumdis-2013-203605 VL - 72 IS - 7 AU - Baptiste Hervier AU - Hervé Devilliers AU - Olivier Benveniste Y1 - 2013/07/01 UR - http://ard.bmj.com/content/72/7/e18.abstract N2 - We read with interest the manuscript by Aggarwal et al1 entitled ‘Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients’. This large cohort study provides important information on outcomes for patients with antisynthetase syndrome (ASS), based on the specificity of the anti-RNA-synthetase autoantibody subtypes. Interestingly, the authors decided to include patients with anti-glycyl (EJ), anti-isoleucyl (OJ) and anti-asparagyl (KS)-tRNA-synthetase autoantibodies, something which had not yet been done in the previous studies,2 ,3 due to … ER -